Literature DB >> 19784941

Psychometric properties of the Coolidge Correctional Inventory in a sample of 3,962 prison inmates.

Frederick L Coolidge1, Daniel L Segal, Kelli J Klebe, Brian S Cahill, Jamie M Whitcomb.   

Abstract

The present study reports on the preliminary psychometric characteristics of a new personality and neuropsychological, 250-item, self-report measure, the Coolidge Correctional Inventory (CCI), in an archival de-identified sample of 3,962 prison inmates. The median internal reliability for the 33 CCI scales and subscales was alpha = .79 (range: alpha = .49 to .93). A prevalence estimate, based on the polythetic criteria in DSM-IV-TR, of at least one personality disorder was 61% of the entire sample, and the prevalence of ADHD was estimated to be 16%. Drug and alcohol problems were also highly prevalent (60%). These results appear to support the preliminary reliability and validity of the CCI and also reveal a high rate of psychopathology and neuropsychological dysfunction among prison inmates. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19784941     DOI: 10.1002/bsl.896

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  3 in total

1.  Suicide risk and mental health co-morbidities in a probationer population.

Authors:  Roberto Cardarelli; Elizabeth Balyakina; Kendra Malone; Kimberly G Fulda; Michael Ellison; Ron Sivernell; Tanjina Shabu
Journal:  Community Ment Health J       Date:  2014-07-29

Review 2.  A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations.

Authors:  S Young; D Moss; O Sedgwick; M Fridman; P Hodgkins
Journal:  Psychol Med       Date:  2014-04-07       Impact factor: 7.723

3.  Association of Schizoid and Schizotypal Personality disorder with violent crimes and homicides in Greek prisons.

Authors:  Athanasios Apostolopoulos; Ioannis Michopoulos; Ioannis Zachos; Emmanouil Rizos; Georgios Tzeferakos; Vasiliki Manthou; Charalambos Papageorgiou; Athanasios Douzenis
Journal:  Ann Gen Psychiatry       Date:  2018-08-10       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.